Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SRS vs HA-WBRT + Memantine for Brain Metastases
NCT03550391Phase 3Recruiting
- Sponsor
- Canadian Cancer Trials Group
- Start
- Nov 2018
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of memantine in brain metastases, sponsored by Canadian Cancer Trials Group. Started Nov 2018; status: recruiting.
02
Drugs
memantine
03
Conditions
brain metastases
Beyond the preview
Go deeper on NCT03550391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03550391.